Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Targeted DNA RNA Sequencing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Targeted DNA RNA Sequencing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Targeted DNA RNA Sequencing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Targeted DNA RNA Sequencing products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Targeted DNA RNA Sequencing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Targeted DNA RNA Sequencing market.
To learn more about this report
Increasing research and development spending on Targeted DNA RNA Sequencing development has been the leading industry trend of Targeted DNA RNA Sequencing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | DNA-based Targeted Sequencing, RNA-based Targeted Sequencing, Other |
| By Application Outlook | Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Illumina, Inc.; F. Hoffmann-La Roche Ltd; Agilent Technologies; GATC Biotech Ag; Oxford Nanopore Technologies; Thermo Fisher Scientific, Inc.; DNASTAR Inc.; QIAGEN; BGI; Perkin Elmer, Inc.; Pacific Biosciences of California, Inc.; Bio-Rad Laboratories, Inc.; Integrated DNA Technologies, Inc.; RainDance Technologies, Inc.; PierianDx; Genomatix GmbH; and Macrogen, Inc. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Targeted DNA RNA Sequencing Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Targeted DNA RNA Sequencing Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Targeted DNA RNA Sequencing Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Targeted DNA RNA Sequencing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 DNA-based Targeted Sequencing
4.2.2 RNA-based Targeted Sequencing
4.2.3 Other
4.4 Type Comparison Matrix
4.5 Global Targeted DNA RNA Sequencing Market Attractiveness, By Type
5 Global Targeted DNA RNA Sequencing Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Targeted DNA RNA Sequencing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Human Biomedical Research
5.3.2 Plant & Animal Sciences
5.3.3 Drug Discovery
5.3.4 Others
5.4 Application Comparison Matrix
5.5 Global Targeted DNA RNA Sequencing Market Attractiveness, by Application
6 Global Targeted DNA RNA Sequencing Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Targeted DNA RNA Sequencing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Targeted DNA RNA Sequencing Market Attractiveness, by Region
8 North America Targeted DNA RNA Sequencing Market Analysis and Forecast
8.1 Key Findings
8.2 North America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 DNA-based Targeted Sequencing
8.2.2 RNA-based Targeted Sequencing
8.2.3 Other
8.3 North America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Human Biomedical Research
8.3.2 Plant & Animal Sciences
8.3.3 Drug Discovery
8.3.4 Others
8.4 North America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Targeted DNA RNA Sequencing Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Targeted DNA RNA Sequencing Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 DNA-based Targeted Sequencing
9.2.2 RNA-based Targeted Sequencing
9.2.3 Other
9.3 Europe Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Human Biomedical Research
9.3.2 Plant & Animal Sciences
9.3.3 Drug Discovery
9.3.4 Others
9.4 Europe Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Targeted DNA RNA Sequencing Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Targeted DNA RNA Sequencing Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 DNA-based Targeted Sequencing
10.2.2 RNA-based Targeted Sequencing
10.2.3 Other
10.3 Asia Pacific Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Human Biomedical Research
10.3.2 Plant & Animal Sciences
10.3.3 Drug Discovery
10.3.4 Others
10.4 Asia Pacific Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Targeted DNA RNA Sequencing Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Targeted DNA RNA Sequencing Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 DNA-based Targeted Sequencing
11.2.2 RNA-based Targeted Sequencing
11.2.3 Other
11.3 Latin America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Human Biomedical Research
11.3.2 Plant & Animal Sciences
11.3.3 Drug Discovery
11.3.4 Others
11.4 Latin America Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Targeted DNA RNA Sequencing Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Targeted DNA RNA Sequencing Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 DNA-based Targeted Sequencing
12.2.2 RNA-based Targeted Sequencing
12.2.3 Other
12.3 Middle East & Africa (MEA) Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Human Biomedical Research
12.3.2 Plant & Animal Sciences
12.3.3 Drug Discovery
12.3.4 Others
12.4 Middle East & Africa (MEA) Targeted DNA RNA Sequencing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Targeted DNA RNA Sequencing Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Illumina
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Inc.; F. Hoffmann-La Roche Ltd; Agilent Technologies; GATC Biotech Ag; Oxford Nanopore Technologies; Thermo Fisher Scientific
13.3.3 Inc.; DNASTAR Inc.; QIAGEN; BGI; Perkin Elmer
13.3.4 Inc.; Pacific Biosciences of California
13.3.5 Inc.; Bio-Rad Laboratories
13.3.6 Inc.; Integrated DNA Technologies
13.3.7 Inc.; RainDance Technologies
13.3.8 Inc.; PierianDx; Genomatix GmbH; and Macrogen
13.3.9 Inc.
14 Key Takeaways
Choose License Type